share_log

NexImmune | DEFA14A: Others

NexImmune | DEFA14A:其他

SEC announcement ·  01/18 00:00
Moomoo AI 已提取核心信息
NexImmune, Inc. has announced the adjournment of its Special Meeting of Stockholders originally scheduled for January 18, 2024, to a new date of February 7, 2024. The meeting, which will be held virtually via live webcast, is set to discuss the approval of the company's liquidation and dissolution as well as the Plan of Liquidation and Dissolution. Stockholders as of the record date, November 6, 2023, are entitled to vote at the rescheduled meeting. The company has provided various methods for stockholders to submit their proxy votes, including over the Internet, by telephone, by mail, or directly at the Special Meeting. Voting will remain open until 11:59 p.m. Eastern Time on February 6, 2024, for Internet and telephone submissions, while mailed proxies must be received by the same date. NexImmune has engaged Laurel Hill Advisory Group, LLC as its proxy solicitor to assist stockholders with the voting process and any related inquiries.
NexImmune, Inc. has announced the adjournment of its Special Meeting of Stockholders originally scheduled for January 18, 2024, to a new date of February 7, 2024. The meeting, which will be held virtually via live webcast, is set to discuss the approval of the company's liquidation and dissolution as well as the Plan of Liquidation and Dissolution. Stockholders as of the record date, November 6, 2023, are entitled to vote at the rescheduled meeting. The company has provided various methods for stockholders to submit their proxy votes, including over the Internet, by telephone, by mail, or directly at the Special Meeting. Voting will remain open until 11:59 p.m. Eastern Time on February 6, 2024, for Internet and telephone submissions, while mailed proxies must be received by the same date. NexImmune has engaged Laurel Hill Advisory Group, LLC as its proxy solicitor to assist stockholders with the voting process and any related inquiries.
NexImmune, Inc.宣布将原定于2024年1月18日举行的股东特别会议延期至2024年2月7日的新日期。该会议将通过网络直播虚拟举行,旨在讨论公司清算和解散以及清算和解散计划的批准。截至创纪录的日期,即2023年11月6日,股东有权在重新安排的会议上投票。该公司为股东提供了多种提交代理投票的方法,包括通过互联网、电话、邮寄或直接在特别会议上提交。互联网和电话提交的投票将持续到美国东部时间2024年2月6日晚上 11:59,而邮寄的代理必须在同一日期之前收到。NexImmune已聘请劳雷尔·希尔咨询集团有限责任公司作为其代理律师,以协助股东进行投票程序和任何相关查询。
NexImmune, Inc.宣布将原定于2024年1月18日举行的股东特别会议延期至2024年2月7日的新日期。该会议将通过网络直播虚拟举行,旨在讨论公司清算和解散以及清算和解散计划的批准。截至创纪录的日期,即2023年11月6日,股东有权在重新安排的会议上投票。该公司为股东提供了多种提交代理投票的方法,包括通过互联网、电话、邮寄或直接在特别会议上提交。互联网和电话提交的投票将持续到美国东部时间2024年2月6日晚上 11:59,而邮寄的代理必须在同一日期之前收到。NexImmune已聘请劳雷尔·希尔咨询集团有限责任公司作为其代理律师,以协助股东进行投票程序和任何相关查询。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息